首页> 外文期刊>Clinical ophthalmology >Management of endophthalmitis while preserving the uninvolved crystalline lens
【24h】

Management of endophthalmitis while preserving the uninvolved crystalline lens

机译:眼内炎的处理,同时保留未受累的晶状体

获取原文
           

摘要

Background: The purpose of this work is to report on the management of endophthalmitis in phakic eyes in which the crystalline lens was preserved.Methods: The current study is a noncomparative consecutive case series of patients who developed culture-proven endophthalmitis and were treated between January 1995 and June 2009. The study included only phakic patients whose infection was managed without removal of the crystalline lens. Using a computerized search of Microbiology Department records, patients were identified with phakic lens status and clinically diagnosed endophthalmitis.Results: A total of 12 phakic eyes from 11 patients met the study criteria. The etiology of infection was endogenous (n = 6), postoperative (n = 5), and post-traumatic (n = 1). Pars plana vitrectomy and injection of intravitreal antimicrobials was performed in seven eyes (58%), and vitreous tap and injection of antimicrobials was performed in five eyes (42%). All eyes showed progression of lens opacification after treatment. Overall, nine (75%) achieved visual acuity outcomes ≥20/80, including five of seven (71%) eyes treated with vitrectomy and four of five eyes (80%) treated with injection of antibiotics alone. One of seven eyes (14%) treated with vitrectomy had a poor visual outcome (defined as <20/400) compared with one of five (20%) eyes treated with intravitreal antimicrobials alone. During follow-up, all 12 eyes had progression of lens opacification and five of 12 (42%) eyes underwent cataract surgery with posterior chamber intraocular lens placement.Conclusion: In phakic patients, successful treatment of endophthalmitis can be achieved while preserving the uninvolved crystalline lens. Future cataract surgery with posterior chamber intraocular lens placement can be accomplished in many of these patients.
机译:背景:这项工作的目的是报告保留晶状体的有晶状体眼的眼内炎的治疗方法。方法:本研究是一系列非对照性连续病例,这些患者发展为经文化证实的眼内炎并于一月间接受治疗1995年和2009年6月。该研究仅包括经晶状体感染治疗且未摘除晶状体的患者。通过对微生物学部门记录的计算机搜索,确定患者有晶状体晶状体状态并经临床诊断为眼内炎。结果:11例患者的12眼有晶状体眼符合研究标准。感染的病因是内源性(n = 6),术后(n = 5)和创伤后(n = 1)。在七只眼(58%)中进行了玻璃体玻璃体切除术和玻璃体内抗菌剂注射,在五只眼(42%)中进行了玻璃体水龙头和抗微生物剂注射。治疗后所有眼睛均显示晶状体混浊。总体而言,有九名(75%)的视力结果≥20/ 80,包括玻璃体切除术治疗的七只眼中的五只(71%)和仅注射抗生素治疗的五只眼中的四只眼(80%)。与仅接受玻璃体内抗生素治疗的五只眼(20%)相比,经玻璃体切除术治疗的七只眼中的一只(14%)的视觉效果较差(定义为<20/400)。随访期间,所有12只眼均发生了晶状体混浊,并且12只眼中的5只(42%)接受了白内障手术并在后房内人工晶状体植入。结论:在有晶状体眼的患者中,可以成功治疗眼内炎并保留不累及的晶状体镜片。在许多这类患者中,将来可以进行后房人工晶状体植入的白内障手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号